Expert Review of Vaccines

Vaccine adverse event reporting: the importance of follow-up
pp. 445-448(4)
Author: Varricchio, Frederick

News in Brief
pp. 449-450(2)

Trial Watch
pp. 451-451(1)

European Union regulatory framework for veterinary vaccines: gateway or obstacle course?
pp. 453-457(5)
Author: Mackay, David

Prevention of hepatitis A by Havrix™: a review
pp. 459-471(13)
Authors: Van Herck, Koen; Van Damme, Pierre

Prospects for a T-cell receptor vaccination against myasthenia gravis
pp. 473-492(20)
Authors: Cohen-Kaminsky, Sylvia; Jambou, Florence

MUC1 as a target antigen for cancer immunotherapy
pp. 493-502(10)
Authors: Acres, Bruce; Limacher, Jean-Marc

Cancer immunotherapy targeting Wilms’ tumor gene WT1 product
pp. 503-512(10)
Author: Sugiyama, Haruo

Therapeutic immunization strategies for the control of HIV-1
pp. 513-520(8)
Author: Dorrell, Lucy

A critical time for rotavirus vaccines: a review
pp. 521-532(12)
Authors: Cunliffe, Nigel A; Nakagomi, Osamu

Vaccines for lyssaviruses other than rabies
pp. 533-540(8)
Author: Nel, Louis H

Tuberculosis: from genome to vaccine
pp. 541-551(11)
Authors: de Jonge, Marien I; Brosch, Roland; Brodin, Priscille; Demangel, Caroline; Cole, Stewart T

Yellow fever vaccine
pp. 553-574(22)
Author: Monath, Thomas P

DNA vaccines against tropical parasitic diseases
pp. 575-589(15)
Authors: Da’dara, Akram A; Harn, Donald A

Regulatory issues for plant-made pharmaceuticals and vaccines
pp. 591-601(11)
Author: Streatfield, Stephen J